Tricia Rodriguez, Truveta senior applied research scientist & lead study author, explains the study findings concerning why ...

Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. Unless you ...

As of September 2024, supply constraints for tirzepatide were reported to be improving, with the product no longer listed on the FDA shortage list ... persistence on GLP-1+ medications and ...

Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance. The approach is especially popular among telemedicine physicians, who ...

While Victoza sales are falling as patients switch to newer, once-weekly drugs ... shortages list, mainly due to pressures on Novo Nordisk's production capacity for its entire GLP-1 franchise ...

Wegovy and Ozempic remain on the FDA's shortages list, despite strenuous efforts ... professionals turning to unapproved versions of GLP-1 drugs as an option for weight loss, saying: "This can ...

Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...